Patents by Inventor Jonas Ekstrand

Jonas Ekstrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GABAreceptor polypeptides and screening methods
    Patent number: 7507543
    Abstract: The present invention relates to a nucleic acid molecule encoding a human or canine GABAB receptor, or a conservative variant thereof.
    Type: Grant
    Filed: September 4, 2002
    Date of Patent: March 24, 2009
    Assignee: AstraZeneca AB
    Inventor: Jonas Ekstrand
  • Human GABAreceptor 1 promoters
    Patent number: 7348163
    Abstract: The present invention relates to nucleic acid molecules constituting GABAB receptor 1 promoters P1a and/or P1b, and to methods for screening for compounds which are modulators of GABAB receptor 1 transcription, said methods comprising the use of nucleic acid molecules constituting GABAB receptor P1a and/or P1b promoters.
    Type: Grant
    Filed: July 7, 2005
    Date of Patent: March 25, 2008
    Assignee: AstraZeneca AB
    Inventors: Anders Edlund, Jonas Ekstrand, Thore Johansson, Göran Leonardsson
  • Human GABAb receptor 1 promoters
    Publication number: 20060019345
    Abstract: The present invention relates to nucleic acid molecules constituting GABAB receptor 1 promoters P1a and/or P1b, and to methods for screening for compounds which are modulators of GABAB receptor 1 transcription, said methods comprising the use of nucleic acid molecules constituting GABAB receptor P1a and/or P1b promoters.
    Type: Application
    Filed: July 7, 2005
    Publication date: January 26, 2006
    Inventors: Anders Edlund, Jonas Ekstrand, Thore Johansson, Goran Leonardsson
  • Human GABAB receptor 1 promoters
    Patent number: 6933124
    Abstract: The present invention relates to nucleic acid molecules constituting GABAB receptor 1 promoters P1a and/or P1b, and to methods for screening for compounds which are modulators of GABAB receptor 1 transcription, said methods comprising the use of nucleic acid molecules constituting GABAB receptor P1a and/or P1b promoters.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: August 23, 2005
    Assignee: AstraZeneca AB
    Inventors: Anders Edlund, Jonas Ekstrand, Thore Johansson, Göran Leonardsson
  • Nucleotide sequences
    Publication number: 20040043448
    Abstract: The present invention relates to a nucleic acid molecule encoding a human or canine GABAB receptor, or a conservative variant thereof.
    Type: Application
    Filed: September 4, 2002
    Publication date: March 4, 2004
    Applicant: Astra Aktiebolag, a Swedish corporation
    Inventor: Jonas Ekstrand
  • Nucleotide sequences
    Patent number: 6465213
    Abstract: The present invention relates to a nucleic acid molecule encoding a human or canine GABAB receptor, or a conservative variant thereof.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: October 15, 2002
    Assignee: Astra Aktiebolag
    Inventor: Jonas Ekstrand